Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

Breast Reconstruction Decision Aid (RECONJOINT)

Status: Recruiting
Location: See all (8) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Focus Group Participants

• A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record

• ≥18 years old

• Considering post-mastectomy breast reconstruction

⁃ RCT Participants (Patients)

• A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record

• ≥18 years old

• Considering post-mastectomy breast reconstruction

• Have an appointment scheduled for consultation with a plastic surgery provider

⁃ RCT Participants (Physicians)

• Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.

Locations
United States
North Carolina
Duke Cancer Institute (Data collection only)
NOT_YET_RECRUITING
Durham
New Jersey
Memorial Sloan Kettering Basking Ridge
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth
RECRUITING
Middletown
Memorial Sloan Kettering Bergen
RECRUITING
Montvale
New York
Memorial Sloan Kettering Commack
RECRUITING
Commack
Memorial Sloan Kettering Westchester
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center
RECRUITING
New York
Memorial Sloan Kettering Nassau
RECRUITING
Rockville Centre
Contact Information
Primary
Evan Matros, MD
matrose@mskcc.org
646-608-8044
Backup
Carrie Stern, MD
sternc2@mskcc.org
646-608-8048
Time Frame
Start Date: 2026-01-05
Estimated Completion Date: 2029-01-05
Participants
Target number of participants: 131
Treatments
No_intervention: Focus Group Participants
Participants will receive usual care
Experimental: RECONJOINT/RCT Participants (Patients)
Participants in the RECONJOINT intervention arm will receive the decision aid in addition to enhanced usual care
Experimental: RCT Participants (Physicians)
Participating surgeons will be randomized to Enhanced Usual Care or Intervention with a 1:1 ratio
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov